Literature DB >> 22101211

Constitutive androstane receptor transactivates the hepatic expression of mouse Dhcr24 and human DHCR24 encoding a cholesterogenic enzyme 24-dehydrocholesterol reductase.

Kouichi Yoshinari1, Hitoshi Ohno, Satoshi Benoki, Yasushi Yamazoe.   

Abstract

Phenobarbital treatment has long been known to influence serum and hepatic cholesterol levels in rodents and humans. Constitutive androstane receptor (CAR), a member of the nuclear receptor superfamily, mediates various biological actions of phenobarbital. We have thus investigated whether CAR transactivates cholesterogenic genes in livers. Activation of CAR in mouse livers and cultured human hepatocytes increased mRNA levels of mouse Dhcr24 and human DHCR24, both of which encode 24-dehydrocholesterol reductase (DHCR24) catalyzing the last step of cholesterol biosynthesis. CAR transactivated the expression of these genes in reporter assays with cultured hepatoma cells. Furthermore, we have identified a DR4 (direct repeat separated by 4 nucleotides) motif in the human DHCR24 distal promoter as a binding site of CAR/retinoid X receptor α (RXRα) heterodimer. We have also demonstrated that the heterodimer of pregnane X receptor (PXR)/ RXRα binds to the DR4 motif and that human DHCR24 reporter gene is transactivated by the ligand-activated PXR. These results suggest a role of xenobiotic-responsive nuclear receptor CAR, and also possibly PXR, in cholesterol biosynthesis in the liver of mice and humans.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101211     DOI: 10.1016/j.toxlet.2011.11.003

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  8 in total

Review 1.  Novel functions of PXR in cardiometabolic disease.

Authors:  Changcheng Zhou
Journal:  Biochim Biophys Acta       Date:  2016-02-26

2.  Structure of the retinoid X receptor α-liver X receptor β (RXRα-LXRβ) heterodimer on DNA.

Authors:  Xiaohua Lou; Gudrun Toresson; Cindy Benod; Ji Ho Suh; Kevin J Philips; Paul Webb; Jan-Ake Gustafsson
Journal:  Nat Struct Mol Biol       Date:  2014-02-23       Impact factor: 15.369

3.  Bioinformatic analysis of microRNA networks following the activation of the constitutive androstane receptor (CAR) in mouse liver.

Authors:  Ruixin Hao; Shengzhong Su; Yinan Wan; Frank Shen; Ben Niu; Denise M Coslo; Istvan Albert; Xing Han; Curtis J Omiecinski
Journal:  Biochim Biophys Acta       Date:  2016-04-11

4.  Coordinated roles of pregnane X receptor and constitutive androstane receptor in autoinduction of voriconazole metabolism in mice.

Authors:  Masato Ohbuchi; Kouichi Yoshinari; Hayato Kaneko; Satoru Matsumoto; Akiko Inoue; Akio Kawamura; Takashi Usui; Yasushi Yamazoe
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

Review 5.  Role of CAR and PXR in xenobiotic sensing and metabolism.

Authors:  Yue-Ming Wang; Su Sien Ong; Sergio C Chai; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-05-03       Impact factor: 4.481

6.  Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis.

Authors:  Winnie Luu; Eser J Zerenturk; Ika Kristiana; Martin P Bucknall; Laura J Sharpe; Andrew J Brown
Journal:  J Lipid Res       Date:  2013-12-20       Impact factor: 5.922

7.  Promoter analysis of the DHCR24 (3β-hydroxysterol Δ(24)-reductase) gene: characterization of SREBP (sterol-regulatory-element-binding protein)-mediated activation.

Authors:  Lidia A Daimiel; María E Fernández-Suárez; Sara Rodríguez-Acebes; Lorena Crespo; Miguel A Lasunción; Diego Gómez-Coronado; Javier Martínez-Botas
Journal:  Biosci Rep       Date:  2012-12-06       Impact factor: 3.840

8.  Insights into hepatopancreatic functions for nutrition metabolism and ovarian development in the crab Portunus trituberculatus: gene discovery in the comparative transcriptome of different hepatopancreas stages.

Authors:  Wei Wang; Xugan Wu; Zhijun Liu; Huajun Zheng; Yongxu Cheng
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.